QR code

Real-world treatment and retreatment patterns and outcomes in patients with advanced or metastatic non-small cell lung cancer following nivolumab monotherapy in second line or later in France: an I-O Optimise analysis

IntroductionThis study describes treatment and retreatment patterns and outcomes in patients in France following nivolumab as a second-line or later (2L+) treatment in locally advanced or metastatic non-small cell lung cancer (LAM NSCLC).Materials and methodsThis analysis included adults with tumor,...

Volledige beschrijving

Bewaard in:
Hoofdauteurs: Grégoire Justeau, Christos Chouaid, Didier Debieuvre, Clarisse Audigier-Valette, Xavier Quantin, Hervé Léna, Lise Bosquet, Nicolas Girard, Minouk J. Schoemaker, Marta Mella, Bárbara Pinto Correia, Caroline Rault, Melinda J. Daumont, John R. Penrod, Adam Lee, Maurice Pérol
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Frontiers Media S.A. 2025-02-01
Reeks:Frontiers in Oncology
Onderwerpen:
real-world
immunotherapy
NSCLC
retreatment
rechallenge
PD-L1 expression
Online toegang:https://www.frontiersin.org/articles/10.3389/fonc.2025.1526931/full
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items